Triangle

 

 

Abstract Submission

Call for Abstract Submissions

Researchers, clinicians, and professionals in cancer research are invited to submit abstracts for presentation at ICRS2025. This is an opportunity to showcase innovative research and contribute to the global fight against cancer.

Abstract themes include:

  • Epidemiology
  • Genetics
  • Cancer in Southeast Asia
  • Predisposition
  • Environmental Risk Factors
  • Multiomics
  • Artificial Intelligence in Cancer
  • Spatial Biology
  • Machine Learning
  • Digital Healthcare
  • Computational Tools and Analysis
  • Biomarker Discovery
  • Tumour Ecosystem
  • Metastasis
  • Tumour Microenvironment
  • Cancer Microbiome
  • Drug Resistance
  • Recurrence
  • Molecular Mechanisms
  • Innovative Approaches
  • Emerging Advances
  • Precision Medicine
  • Immunotherapy
  • Cancer Vaccines
  • Theranostics
  • Immunoediting

 

How to submit:

  1. Create an account on Microsoft CMT and submit your abstract through the system by 16 February 2025.
  2. Abstract acceptance will be notified through email on 16 March 2025.
  3. After confirming your acceptance, please submit your poster or slides on Microsoft CMT by 7 May 2025.

Abstract Submission Guidelines

  • Abstracts must be written in clear English (UK). 

  • Please enter the title and the body of your abstract in the submission form 

  • All abstracts should be submitted through Microsoft CMT by 11:59PM, 16 February 2025 (+8 GMT). 

  • Abstracts should be written with the information as follows:  

Title 

Abstract title should be less than 30 words and be in Title Case, in bold font.  e.g.  

“Effects of Treatment X on Cancer”. 

Author 

Author’s name must be written in full. List any institutional affiliation, state, and country.  

Abstract Body 

Abstracts should not exceed 300 words 

Keywords 

5 keywords 

 
Disclaimer: 

  • It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.  

  • Authors should avoid submitting a title or an abstract that has been previously published in a journal or presented at another conference. If the work has been presented before, authors are encouraged to include new data or insights. All submissions should be original. 

  • By submitting your abstract, you agree to grant permission for the ICRS 2025 Organising Committee to publish your abstract in our proceedings.  

How to register for Microsoft CMT (skip this if you already have a Microsoft CMT account) 

  1. Go to our Microsoft CMT page: https://cmt3.research.microsoft.com/ICRS2025 

  1. Click on Register. 

  1. Enter your details in the registration page. 

  1. Check your e-mail for an activation link and click on it to verify your account. 

  1. Return to our Microsoft CMT page and log in. 

How to submit on Microsoft CMT 

  1. Go to our Microsoft CMT page: https://cmt3.research.microsoft.com/ICRS2025 

  1. Register for an account or log in if you have an existing account. 

  1. Click “Create new submission” and choose “Poster and Oral Presenters”. 

  1. Fill up the submission form: 

  • Enter your abstract title and the body of your abstract in the empty fields. 

  • Select subject areas relevant to your work. 

  • Upload your full abstract (with authors, affiliations, etc.) in word document format. 

  • Specify whether you are requesting to present as oral or poster presenter. 

  1. After you submit the form, you will be prompted to specify any conflicts of interest. You may proceed and click “Done” on the bottom left of the screen. 

  1. Upon receiving your abstract acceptance notification, you may upload your presentation slides or poster under the “supplementary material” section. 

Note: The supplementary material section will only be visible after you have submitted your abstract. 

Why Submit?

  • Present your research to an international audience of experts and peers.
  • Selected abstracts will be eligible for awards, and top presentations will be featured in the symposium’s proceedings.
  • Engage with leading researchers and clinicians, fostering collaborations and expanding your professional network.
  • Play a role in advancing knowledge and innovations that can impact cancer treatment and care worldwide.